---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-156043"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T06:06:41.880267+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Teva shareholders elect four directors, approve say-on-pay and auditor at annual meeting

## Summary
- Elected Prof. Varda Shalev to board through 2026; Rosemary Crane, Gerald Lieberman, Prof. Ronit Satchi-Fainaro through 2027.
- Non-binding advisory vote on executive compensation approved: 571,822,049 for vs 120,609,632 against.
- Shareholders recommended annual advisory vote on exec comp (one-year frequency) with 536,980,720 votes.
- Ratification of Kesselman & Kesselman (PwC) as independent auditor approved: 731,150,255 for, 30,335,560 against.

## SEC filing metadata
- accession: 0001193125-24-156043
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312524156043/0001193125-24-156043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312524156043/d841419d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-156043
- JSON: https://secwatch.observer/filing/0001193125-24-156043.json
- Plain text: https://secwatch.observer/filing/0001193125-24-156043.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.